Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Haematology-Oncology Associates of Ohio and Michigan, PC
801
mi
from
Lambertville, MI
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Haematology-Oncology Associates of Ohio and Michigan, PC
801
mi
from
Lambertville, MI
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Community Cancer Center of Monroe
817
mi
from
Monroe, MI
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Community Cancer Center of Monroe
817
mi
from
Monroe, MI
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mercy Memorial Hospital - Monroe
816
mi
from
Monroe, MI
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mercy Memorial Hospital - Monroe
816
mi
from
Monroe, MI
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
MeritCare Bemidji
690
mi
from
Bemidji, MN
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
MeritCare Bemidji
690
mi
from
Bemidji, MN
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mayo Clinic Cancer Center
515
mi
from
Rochester, MN
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mayo Clinic Cancer Center
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
CCOP - Missouri Valley Cancer Consortium
259
mi
from
Omaha, NE
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
CCOP - Missouri Valley Cancer Consortium
259
mi
from
Omaha, NE
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Immanuel Medical Center
265
mi
from
Omaha, NE
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Immanuel Medical Center
265
mi
from
Omaha, NE
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Alegent Health Cancer Center at Bergan Mercy Medical Center
258
mi
from
Omaha, NE
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Alegent Health Cancer Center at Bergan Mercy Medical Center
258
mi
from
Omaha, NE
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Creighton University Medical Center
262
mi
from
Omaha, NE
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Creighton University Medical Center
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Bismarck Cancer Center
645
mi
from
Bismarck, ND
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Bismarck Cancer Center
645
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Medcenter One Hospital Cancer Care Center
645
mi
from
Bismarck, ND
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Medcenter One Hospital Cancer Care Center
645
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mid Dakota Clinic, PC
645
mi
from
Bismarck, ND
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mid Dakota Clinic, PC
645
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
St. Alexius Medical Center Cancer Center
647
mi
from
Bismarck, ND
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
St. Alexius Medical Center Cancer Center
647
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
CCOP - MeritCare Hospital
635
mi
from
Fargo, ND
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
CCOP - MeritCare Hospital
635
mi
from
Fargo, ND
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Sanford Broadway Clinic
635
mi
from
Fargo, ND
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Sanford Broadway Clinic
635
mi
from
Fargo, ND
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Wood County Oncology Center
793
mi
from
Bowling Green, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Wood County Oncology Center
793
mi
from
Bowling Green, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Fremont Memorial Hospital
819
mi
from
Fremont, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Fremont Memorial Hospital
819
mi
from
Fremont, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Lima Memorial Hospital
762
mi
from
Lima, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Lima Memorial Hospital
762
mi
from
Lima, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Northwest Ohio Oncology Center
796
mi
from
Maumee, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Northwest Ohio Oncology Center
796
mi
from
Maumee, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
St. Luke's Hospital
796
mi
from
Maumee, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
St. Luke's Hospital
796
mi
from
Maumee, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
St. Charles Mercy Hospital
806
mi
from
Oregon, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
St. Charles Mercy Hospital
806
mi
from
Oregon, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Toledo Clinic - Oregon
807
mi
from
Oregon, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Toledo Clinic - Oregon
807
mi
from
Oregon, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Firelands Regional Medical Center
842
mi
from
Sandusky, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Firelands Regional Medical Center
842
mi
from
Sandusky, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
North Coast Cancer Care, Incorporated
842
mi
from
Sandusky, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
North Coast Cancer Care, Incorporated
842
mi
from
Sandusky, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Flower Hospital Cancer Center
796
mi
from
Sylvania, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Flower Hospital Cancer Center
796
mi
from
Sylvania, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Mercy Hospital of Tiffin
814
mi
from
Tiffin, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Mercy Hospital of Tiffin
814
mi
from
Tiffin, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Toledo Hospital
801
mi
from
Toledo, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Toledo Hospital
801
mi
from
Toledo, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
St. Vincent Mercy Medical Center
805
mi
from
Toledo, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
St. Vincent Mercy Medical Center
805
mi
from
Toledo, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Medical University of Ohio Cancer Center
799
mi
from
Toledo, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Medical University of Ohio Cancer Center
799
mi
from
Toledo, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
CCOP - Toledo Community Hospital
803
mi
from
Toledo, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
CCOP - Toledo Community Hospital
803
mi
from
Toledo, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Toledo Clinic, Incorporated - Main Clinic
800
mi
from
Toledo, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Toledo Clinic, Incorporated - Main Clinic
800
mi
from
Toledo, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Fulton County Health Center
772
mi
from
Wauseon, OH
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Fulton County Health Center
772
mi
from
Wauseon, OH
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Avera Cancer Institute
403
mi
from
Sioux Falls, SD
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Avera Cancer Institute
403
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Medical X-Ray Center, PC
402
mi
from
Sioux Falls, SD
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Medical X-Ray Center, PC
402
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Sanford Cancer Center at Sanford USD Medical Center
408
mi
from
Sioux Falls, SD
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Sanford Cancer Center at Sanford USD Medical Center
408
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Fredericksburg Oncology, Incorporated
1106
mi
from
Fredericksburg, VA
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Fredericksburg Oncology, Incorporated
1106
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated:  11/30/2016
Franciscan Skemp Healthcare - La Crosse Campus
541
mi
from
La Crosse, WI
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm
Status: Enrolling
Updated: 11/30/2016
Franciscan Skemp Healthcare - La Crosse Campus
541
mi
from
La Crosse, WI
Click here to add this to my saved trials
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Status: Enrolling
Updated:  11/30/2016
Medical College of GeorgiaDept of OBGYN
935
mi
from
Augusta, GA
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Status: Enrolling
Updated: 11/30/2016
Medical College of GeorgiaDept of OBGYN
935
mi
from
Augusta, GA
Click here to add this to my saved trials
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Status: Enrolling
Updated:  11/30/2016
University of MinnesotaObstetrics & Gynecology, MMC
552
mi
from
Minneapolis, MN
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Status: Enrolling
Updated: 11/30/2016
University of MinnesotaObstetrics & Gynecology, MMC
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Status: Enrolling
Updated:  11/30/2016
Ohio State University
810
mi
from
Columbus, OH
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Status: Enrolling
Updated: 11/30/2016
Ohio State University
810
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
1168
mi
from
Los Angeles, CA
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
1328
mi
from
Palo Alto, CA
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
1328
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
1339
mi
from
San Francisco, CA
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
657
mi
from
Louisville, KY
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
657
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
1148
mi
from
Baltimore, MD
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
552
mi
from
Minneapolis, MN
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
262
mi
from
Omaha, NE
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
262
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
1383
mi
from
Portland, OR
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
467
mi
from
Memphis, TN
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
467
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated:  11/30/2016
Clinical Research Facility
368
mi
from
Lubbock, TX
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy
Status: Enrolling
Updated: 11/30/2016
Clinical Research Facility
368
mi
from
Lubbock, TX
Click here to add this to my saved trials